AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

DemensiaKITA Mobile Health App to Improve Knowledge, Attitude, Practice and Reduce Burden Among Dementia Caregivers in Malaysia

RecruitingNAAges 18 Years - anyAllUniversiti Teknologi Mara
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Dementia is a growing health concern in Malaysia and places a heavy burden on family members who act as caregivers. Many caregivers struggle with limited knowledge, negative attitudes, and challenges in daily caregiving practices. These issues increase caregiver stress and reduce the quality of care for people living with dementia. The DemensiaKITA mobile health application was developed to support caregivers by providing educational content, self-help tools, and practical guidance. This study will evaluate whether using the DemensiaKITA app can improve caregivers' knowledge, attitudes, and caregiving practices (KAP), as well as reduce caregiver burden. This is a non-randomized controlled trial involving dementia caregivers in Kuala Lumpur and Selangor. Participants in the intervention group will use the DemensiaKITA mobile app for a set period, while the control group will continue wi

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Adults aged 18 years and above * Primary informal caregiver of a person living with dementia (family member or household member) * Able to read and understand Malay * Owns a smartphone and is able to use mobile applications * Provides informed consent to participate Exclusion Criteria: * Professional/paid caregivers (e.g., nurses, domestic helpers hired solely for caregiving) * Caregivers of patients with conditions other than dementia * Individuals with severe cognitive or psychiatric illness that limits their ability to participate
๐Ÿ’Š

What it tests

  • DemensiaKITA mobile health application
  • Usual Care
๐Ÿ“

Where

1 site
Universiti Teknologi MARA
Sungai Buloh, Malaysia
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy